Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-26

Clinical Trial Update: Treatment of Tendon Disease Using Autologous Adipose-derived Mesenchymal Stem Cells [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating autologous adipose-derived mesenchymal stem cells for tendon diseases, including rotator cuff tear and lateral epicond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Autologous adipose-derived mesenchymal stem cells (adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Rotator Cuff Tear, Lateral Epicondylitis | Phase 2 | Status: UNKNOWN